Consider this arc: peptides were around in niche communities, GLPs from Pharma then exploded, people realized they could take less or source them elsewhere, regulation enters & now gray & black market are going bye-bye & companies like HIMs & clean compounders are set to soar.
@StockSavvyShay Yes 100%, this is feedback loop is deeply orchestrated within the customer engagement platforms like $BRZE and $ZETA. LLMs itself are not a replacement for such companies
"My largest positions aren’t the ones I think I’m going to make the most money from. My largest positions are the ones where I don’t think I’m going to lose money." -- Joel Greenblatt
$UNH Fantastic opportunity here
- Undervalued and below 200 wma
- A 2.7% forward dividend yield at a share price around 328 dollars
- Potential ACA extension this month
- Buffett bought it
Oscar CEO, @mtbert, has been named to @modrnhealthcr's 100 Most Influential People in Healthcare.
It’s great to be recognized alongside leaders who are shaping the next era of healthcare and the efforts to drive this recognition.
As we expand into new markets and introduce new offerings – including plans for menopause care and chronic conditions and investment in technology via our @OpenAI-powered health agent, Oswell, for Open Enrollment, we’re building what Mark calls “insurance for real life.”
Thank you to our employees, members, and partners who are helping us deliver a simpler, more personalized experience to more people across the country.
https://t.co/kusbQiMv1K
Fusaka is live on Ethereum mainnet!
- PeerDAS now unlocks 8x data throughput for rollups
- UX improvements via the R1 curve & pre-confirmatons
- Prep for scaling the L1 with gas limit increase & more
Community members will continue to monitor for issues over the next 24 hrs.